Two U.S. senators say it’s time for U.S. Anesthesia Partners and its parent company, Welsh, Carson, Anderson & Stowe, a private equity firm, to pay the piper following the Federal Trade Commission’s anticompetitive scheme lawsuit in late September.
Read the full post on Becker's Hospital Review - Healthcare News
